Englander Institute for Precision Medicine
Found 887 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2026
Morris G, Vlachostergios PJ, Rai MP, Scherr D, Molina A, Elemento O, Mosquera JMiguel, Cheng L, Faltas BM.  2026.  19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.. Cancer Genet. 304-305:51-57.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..  2026.  Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 6(1)
Xu C, Xu J, Bulusu KC, Pan H, Elemento O.  2026.  BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual language model.. bioRxiv.
Mak L, Tierney B, Wei W, Ronkowski C, Toscan RBrizola, Turhan B, Toomey M, Andrade-Martinez JSebastian, Fu C, Lucaci AG et al..  2026.  CAMP: a modular metagenomics analysis system for integrated multistep data exploration.. NAR Genom Bioinform. 8(1):lqaf172.
Schranner D, Wackerhage H, Weinisch P, Schlegel J, Bremer S, Scherr J, Römisch-Margl W, Riermeier A, Zelger O, Stöcker F et al..  2026.  Characterizing Human Oxidative, Anabolic and Glycolytic Metabolism in Athletes with Extreme Physiologies.. Sports Med Open. 12(1)
Agarwal PK, Sternberg CN.  2026.  Clinical trials corner issue 12(1).. Bladder Cancer. 12(1):23523735261424951.
Hsu J, Kim S, Anandasabapathy N.  2026.  Correction: Hsu et al. Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity. Viruses 2024, 16, 870.. Viruses. 18(4)
Evans AT, Rehani E, Smith B, Hong MD, Lewin Z, Hiroshige K, Spandorfer SD, Hajirasouliha I, Lujan ME, Hoeger KM.  2026.  Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features.. O G Open. 3(2):e161.
Waltman P, Chandra P, Eng KW, Wilkes DC, Park H, Pabon C, Delpe P, Bhinder B, Manohar J, Kane T et al..  2026.  EXaCT-2: an augmented and customizable oncology-focused whole exome sequencing platform.. NPJ Precis Oncol.
Kaza S, Mohanty AS, Serpedin A, Yau J, Kim YEun, Kutler RB, Elemento O, Sulica L, Khosravi P, Rameau A.  2026.  Exploring Real-Time Tracking of Vocal Fold Polyps in Video-Stroboscopy Using Deep Learning.. Laryngoscope.
Stephan N, Halama A, Thareja G, Sarwath H, Grallert H, Peters A, Gieger C, Schmidt F, Graumann J, Suhre K.  2026.  Identification of Protein Signatures Reflecting Latent Variation in Aptamer-Based Affinity Proteomics.. J Proteome Res.
Uppal M, Bhinder B, Marderstein AR, Batlevi CLee, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD et al..  2026.  Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.. J Clin Oncol. :JCO2501928.
Bleve S, Ravera F, Rodrigues S, Pederzoli F, Pakula H, Brighi N, Giunta EFrancesco, Schepisi G, Virga A, Gurioli G et al..  2026.  Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.. Prostate Cancer Prostatic Dis.
Chaudhry F, Kim TWan, Elemento O, Betel D.  2026.  Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson's disease.. Front Aging Neurosci. 18:1730550.
Likasitwatanakul P, Blinka SM, Zarka JG, Gebrael G, Weg E, Longoria O, Moore JA, Sharp A, de Bono J, Sternberg CN et al..  2026.  Molecular landscape of prostate cancers with clival metastases.. Oncologist. 31(4)
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(2):465-480.
Surapaneni S, Kutler RB, Setzen SA, Kim YEun, Yao P, Siddiqui SH, Pitman MJ, Sulica L, Elemento O, Khosravi P et al..  2026.  A Multimodal Approach for Deep-Learning Classification of Vocal Fold Pathologies in Stroboscopy.. Laryngoscope.
Xu C, Us I, Cohen-Setton J, Milo M, Sidders B, Fitzgibbon J, Melnick AM, Pan H, Bulusu KC, Elemento O.  2026.  PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.. Res Sq.
Xing Y, Reznikov I, Ahmed ANur, Sidhu I, Wisnewski J, Farhat A, Prystupa A, Konieczny P, Mansfield K, Cooper ML et al..  2026.  Peripheral immune-inducer dendritic cells drive early-life allergic inflammation.. Nature.
De Boni L, Claridge S, Nath S, Tofani K, Stein BD, Park E, Steiner S, Elemento O, Pauli C, Hopkins BD.  2026.  Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors.. iScience. 29(3):114954.
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Publisher Correction: Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(3):666.
Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, Rosales M, Haas GP, Saad F, Hussain M et al..  2026.  Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2402829.
Maushagen J, Grune E, Schlett CL, Kiefer LSophie, Suhre K, Adamski J, Wang-Sattler R, Peters A, Bamberg F, Rospleszcz S.  2026.  Serum metabolite patterns of adipose tissue distribution and body composition subphenotypes.. Lipids Health Dis. 25(1)
Marulanda-Corzo V, Kakkar P, Sharbatdaran A, Sternberg CN, Huicochea-Castellanos S.  2026.  Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare.. Clin Nucl Med.
Nazzaro M, Mardis ER, Canella A, Bhinder B, Elemento O, Behbehani G, Currier M, Glaspell A, Lee DA, Cripe TP et al..  2026.  Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.. Mol Ther Oncol. 34(1):201147.